C. Baker

发表

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

Jennifer K. Sun, L. Aiello, N. Bressler, 2015, The New England journal of medicine.

A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE).

Jennifer K. Sun, Judy E. Kim, L. Aiello, 2021, Ophthalmology. Retina.

Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals

Z. Haskova, A. Antoszyk, C. Baker, 2018, PDA journal of pharmaceutical science and technology.

Evaluation of OCT proven Macular Edema in Post operative Cataract patients operated by Conventional ECCE and SICS techniques

Sandeep, C. Baker, Grover, 2017 .

Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy.

Jennifer K. Sun, Chris A. Johnson, N. Bressler, 2020, JAMA ophthalmology.

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study

I. Scott, N. Oden, B. Blodi, 2019, JAMA ophthalmology.

Recent advancements in diabetic retinopathy treatment from the Diabetic Retinopathy Clinical Research Network

C. Baker, T. Stone, Yi Jiang, 2016, Current opinion in ophthalmology.

Evaluation of masking study participants to intravitreal injections in a randomized clinical trial.

N. Bressler, R. Beck, A. Glassman, 2012, Archives of ophthalmology.

Fluocinolone Acetonide Intravitreal Implant in Patients with Diabetic Macular Edema: 12 Month Results

P. A. Pearson, D. Eliott, L. Morse, 2003 .

Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.

Jennifer K. Sun, L. Aiello, N. Bressler, 2016, JAMA ophthalmology.

Association of Dietary Nitrate and a Mediterranean Diet With Age-Related Macular Degeneration Among US Adults: The Age-Related Eye Disease Study (AREDS) and AREDS2.

Gertrude S. Fish, E. Agrón, D. Diloreto, 2022, JAMA ophthalmology.

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Jennifer K. Sun, L. Aiello, N. Bressler, 2015, JAMA.

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

Jennifer K. Sun, N. Bressler, R. Beck, 2018, JAMA ophthalmology.

Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.

Jeffrey Heier, Jason Hsu, Tracey Caldwell, 2018, Ophthalmology.

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.

Jennifer K. Sun, D. Browning, S. Grover, 2019, JAMA.

Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.

Jennifer K. Sun, F. Ferris, M. Maguire, 2022, The New England journal of medicine.

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

Rishi P. Singh, R. Shah, P. Campochiaro, 2022, The Lancet.

A Step Forward in Understanding Treatment Approaches for Diabetic Macular Edema.

Jennifer K. Sun, L. Jampol, C. Baker, 2022, JAMA ophthalmology.

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).

Jennifer K. Sun, M. Elman, M. Maguire, 2020, Ophthalmology.

TOPICAL NEPAFENEC IN EYES WITH NONCENTRAL DIABETIC MACULAR EDEMA

N. Bressler, M. Elman, L. Jampol, 2015, Retina.

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.

Jennifer K. Sun, Daniel F. Martin, L. Jampol, 2023, JAMA.

Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema.

N. Bressler, T. Murtha, S. Grover, 2013, JAMA ophthalmology.

Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.

Lloyd Paul Aiello, Jared Nielsen, Neil M Bressler, 2015, JAMA ophthalmology.

Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to eETDRS Protocol Visual Acuity Assessment.

Jennifer K. Sun, M. Maguire, Daniel F. Martin, 2022, Ophthalmology.

Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.

Jennifer K. Sun, N. Bressler, C. Wykoff, 2020, JAMA ophthalmology.

Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial

Jennifer K. Sun, Chris A. Johnson, M. Maguire, 2021, Translational vision science & technology.

Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial

R. Shah, P. Campochiaro, S. Gupta, 2023, Japanese Journal of Ophthalmology.

Pilot study of individuals with diabetic macular edema undergoing cataract surgery.

N. Bressler, S. Bressler, P. Edwards, 2014, JAMA ophthalmology.

Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.

Stephen F. Hobbs, Christina Y. Weng, Robert C. Wang, 2019, Ophthalmology.

PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial

N. Bressler, Dennis P. Han, G. Jaffe, 2017, Retina.

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Quan Dong Nguyen, J. Sy, Q. Nguyen, 2012, Ophthalmology.

Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.

Stephen F. Hobbs, Sharon D. Solomon, Arthur D. Fu, 2019, Ophthalmology.

Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.

Stephen F. Hobbs, Arthur D. Fu, Jennifer I. Lim, 2018, Ophthalmology.

Pilot study of individuals with diabetic macular edema undergoing cataract surgery.

N. Bressler, S. Bressler, P. Edwards, 2014, JAMA ophthalmology.

Effect of Azithromycin on Lipid Accumulation in Immortalized Human Meibomian Gland

N. Bressler, S. Bressler, P. Edwards, 2014 .

Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.

P. Campochiaro, C. Regillo, D. Rosberger, 2023, Ophthalmology.